GlassScriptPhysician profile
Stephanie M Parks
NPI 1760747844
$4,215.14
in general payments reported to CMS, 2019-2025
21 companies · $1,096 in 2025
The $1,096 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $338 · 2021: $797 · 2022: $214 · 2023: $486 · 2024: $789 · 2025: $1,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,123 · Long Term Medical Supply Or Device Loan: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,122.91 |
| Long Term Medical Supply Or Device Loan | $247.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,025.79 | 2019-2025 | Stravix Pl, Grafix Pl, Footprint |
| Stryker Corporation | $895.03 | 2019-2025 | Biofoam, Valor, Viaflow |
| Kerecis Limited | $810.87 | 2021-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $303.82 | 2021-2024 | Puraply |
| Integra Lifesciences Corporation | $283.98 | 2019-2025 | Integra, Micromatrix |
| Orthofix Medical, INC. | $128.28 | 2019-2025 | Physio-Stim |
| Paratek Pharmaceuticals, INC. | $120.26 | 2024-2025 | Nuzyra |
| Cardiovascular Systems INC. | $109.40 | 2019 | |
| Medical Device Business Services, INC. | $77.05 | 2024 | Fibulink |
| Reprise Biomedical, INC. | $75.58 | 2025 | Miro3d, Mirodry |
| Osiris Therapeutics INC. | $63.94 | 2019 | |
| Medtronic, INC. | $51.83 | 2025 | Inceptiv |
| Bioventus LLC | $51.10 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Treace Medical Concepts, INC. | $50.60 | 2022-2023 | |
| Mimedx Group, INC. | $39.54 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $35.81 | 2025 | |
| Nevro Corp. | $28.99 | 2024 | Senza |
| Biocomposites INC | $18.27 | 2025 | Stimulan |
| Wright Medical Technology, INC. | $15.40 | 2019 | |
| Kci USA, INC. | $15.35 | 2019 | |
| Baxter Healthcare | $14.25 | 2025 | Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Parks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.